Background illustration for clinical trials search

Paid Clinical Trials Newport

Discover 489 paid clinical trials in Newport, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Project CORE: Disseminating Eating Disorders Treatment

for
Anorexia Nervosa/Bulimia, Anorexia Nervosa Restricting Type,
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 12 - 18

Code: NCT03855553

Phase 1, Recruiting

Control Systems Engineering for Weight Loss Maintenance

for
Overweight and Obesity
Location: Providence RI
Sponsor: The Miriam Hospital

Sex: All

Age: 18 - 70

Code: NCT06244888

Phase 2, Recruiting

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Providence RI, Boston MA, New York NY, Detroit MI,
Sponsor: AstraZeneca

Sex: Male

Age: 18 - 70+

Code: NCT07181161

Phase 1, Phase 2, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Providence RI, Hartford CT, New Haven CT,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

Implementing a Brief Suicide Intervention for High Risk Youth With Front-Line Juvenile Justice Staff

for
Suicide and Self Harm
Location: Providence RI
Sponsor: Rhode Island Hospital

Sex: All

Age: 12 - 17

Code: NCT02981420

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

for
Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma,
Location: Providence RI, Boston MA, New York NY, Hackensack NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06564038

Phase 1, Phase 2, Recruiting

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

for
Gastric Cancer, Gastroesophageal Junction Cancer,
Location: Providence RI, Commack NY, Sherbrooke, Montreal,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06219941

Phase 2, Recruiting

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

for
Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer,
Location: Providence RI, Boston MA, Montreal, Fairfax VA, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05797168

Phase 1, Phase 2, Recruiting

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

for
Advanced or Metastatic Non-small Cell Lung Cancer
Location: Providence RI, Baltimore MD, Cleveland OH,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06996782

Phase 1, Phase 2, Recruiting

Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

for
Solid Tumours
Location: Providence RI, New York NY, Fairfax VA, Houston TX
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07446855

Phase 1, Phase 2, Recruiting

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

for
Biliary Tract Cancer
Location: Providence RI, Hartford CT, New Haven CT, Mineola NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07221253

Phase 3, Recruiting

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

for
Prostate Cancer
Location: Providence RI, Commack NY, Quebec, Grand Rapids MI,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT07192614

Phase 1, Phase 2, Recruiting

A Study of DS5361b in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Providence RI, Fairfax VA, Sarasota FL, Irving TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07182591

Phase 1, Recruiting

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for
Prostate Cancer
Location: Providence RI, Plymouth MA, New York NY, Hackensack NJ,
Sponsor: AstraZeneca

Sex: Male

Age: 18+

Code: NCT06952803

Phase 3, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Providence RI, Brookline MA, Boston MA, Waterbury CT,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors

for
Advanced Solid Tumors That Are MTAP Deficient
Location: Providence RI, New Haven CT, Baltimore MD, Fairfax VA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06130553

Phase 1, Phase 2, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Providence RI, Boston MA, The Bronx NY, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase 3, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Providence RI, New Haven CT, Stony Brook NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase 3, Recruiting

Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building

for
Alcohol Use Disorder (AUD), PTSD
Location: Providence RI
Sponsor: University of Rhode Island

Sex: All

Age: 18+

Code: NCT07217795

Recruiting

L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

for
Acute Myeloid Leukaemia (AML)
Location: Providence RI, Morristown NJ, Philadelphia PA,
Sponsor: Moleculin Biotech, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06788756

Phase 2, Phase 3, Recruiting